Cargando…

Clinicopathological Significance of Tumor Stem Cell Markers ALDH1 and CD133 in Colorectal Carcinoma

BACKGROUND & OBJECTIVE: Colorectal cancer (CRC) is the third most common cancer worldwide with a high mortality rate. The main causes of death in patients are recurrence and metastasis which are mainly attributed to the small subpopulation of cells within tumors called cancer stem cells (CSCs)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Rezaee, Maryam, Gheytanchi, Elmira, Madjd, Zahra, Mehrazma, Mitra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Society of Pathology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691712/ https://www.ncbi.nlm.nih.gov/pubmed/33391379 http://dx.doi.org/10.30699/ijp.2020.127441.2389

Ejemplares similares

Clinical Significance of Cancer Stem Cell Markers CD133 and CXCR4 in Osteosarcomas
por: Mardani, Azam, et al.
Publicado: (2020)

Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer
por: Kalantari, Elham, et al.
Publicado: (2022)

Expressions of TWIST1 and CD105 markers in colorectal cancer patients and their association with metastatic potential and prognosis
por: Fattahi, Fahimeh, et al.
Publicado: (2021)

Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma
por: ZHOU, FEI, et al.
Publicado: (2014)

Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas
por: Rasti, Arezoo, et al.
Publicado: (2018)

Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer
por: Kim, Sung Jeep, et al.
Publicado: (2015)

Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer"
por: Ieni, Antonio, et al.
Publicado: (2016)

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
por: Lugli, A, et al.
Publicado: (2010)

SMAD4 Expression in Renal Cell Carcinomas Correlates With a Stem-Cell Phenotype and Poor Clinical Outcomes
por: Rasti, Arezoo, et al.
Publicado: (2021)

Monosomy 3 by chromogenic in situ hybridization (CISH) in Iranian patients with uveal melanoma
por: Naseripour, Masood, et al.
Publicado: (2015)

Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma
por: Suman, Sweta, et al.
Publicado: (2023)

The Clinicopathological Significance of miR-133a in Colorectal Cancer
por: Wan, Timothy Ming-Hun, et al.
Publicado: (2014)

Morphological and molecular characteristics of spheroid formation in HT-29 and Caco-2 colorectal cancer cell lines
por: Gheytanchi, Elmira, et al.
Publicado: (2021)

Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis
por: Han, Zhengquan, et al.
Publicado: (2015)

Immunomodulatory-based therapy as a potential promising treatment strategy against severe COVID-19 patients: A systematic review
por: Razmi, Mahdieh, et al.
Publicado: (2020)

Low expression of Talin1 is associated with advanced pathological features in colorectal cancer patients
por: Vafaei, Somayeh, et al.
Publicado: (2020)

Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
por: WANG, CHUNXIA, et al.
Publicado: (2012)

ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy
por: Javed, Shifa, et al.
Publicado: (2021)

Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma
por: Yu, Lan, et al.
Publicado: (2014)

Association between ALDH1+/CD133+ stem-like cells and tumor angiogenesis in invasive ductal breast carcinoma
por: LV, XINQUAN, et al.
Publicado: (2016)

Clinicopathologic Significance of Survivin Expression in Relation to CD133 Expression in Surgically Resected Stage II or III Colorectal Cancer
por: Li, Wanlu, et al.
Publicado: (2017)

High expression of DNA damage-inducible transcript 4 (DDIT4) is associated with advanced pathological features in the patients with colorectal cancer
por: Fattahi, Fahimeh, et al.
Publicado: (2021)

Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer" and the "Commentary by Antonio Ieni and Giovanni Tuccari"
por: Fargeas, Christine A., et al.
Publicado: (2016)

Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved
por: Lu, Li, et al.
Publicado: (2016)

Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol
por: Rasti, Arezoo, et al.
Publicado: (2016)

ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?
por: CZECZKO, Leticia Elizabeth Augustin, et al.
Publicado: (2021)

ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?
por: CZECZKO, Leticia Elizabeth Augustin, et al.
Publicado: (2021)

Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis
por: Gheytanchi, Elmira, et al.
Publicado: (2023)

Clinicopathological characteristics and prognostic value of cancer stem cell marker CD133 in breast cancer: a meta-analysis
por: Li, Zhan, et al.
Publicado: (2017)

Circulating cancer stem cell markers in breast carcinomas: a systematic review protocol
por: Mansoori, Maryam, et al.
Publicado: (2017)

Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
por: Hong, Injae, et al.
Publicado: (2015)

Exosomal microRNAs as potential circulating biomarkers in gastrointestinal tract cancers: a systematic review protocol
por: Gheytanchi, Elmira, et al.
Publicado: (2017)

Expression and Prognostic Significance of Stem Cell Marker CD133 in Survival Rate of Patients with Colon Cancer
por: Ehteram, Hassan, et al.
Publicado: (2022)

BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma
por: Koren, Ana, et al.
Publicado: (2016)

Clinical and prognostic significances of cancer stem cell markers in gastric cancer patients: a systematic review and meta-analysis
por: Razmi, Mahdieh, et al.
Publicado: (2021)

Co-expression of cancer stem cell markers, SALL4/ALDH1A1, is associated with tumor aggressiveness and poor survival in patients with serous ovarian carcinoma
por: Sharbatoghli, Mina, et al.
Publicado: (2022)

Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients
por: Pitule, Pavel, et al.
Publicado: (2014)

The Stem Cell Marker CD133 Associates with Enhanced Colony Formation and Cell Motility in Colorectal Cancer
por: Elsaba, Tarek M. A., et al.
Publicado: (2010)

The Potential Role of CD44 and CD133 in Colorectal Stem Cell Cancer
por: Abdou Hassan, Wael, et al.
Publicado: (2022)

The Prognostic Value of Cancer Stem Cell Markers (CSCs) Expression—ALDH1A1, CD133, CD44—For Survival and Long-Term Follow-Up of Ovarian Cancer Patients
por: Izycka, Natalia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ga7k5g2h46k4n0goqsk4e0ib38